Latest News
A whiteboard saying transition 
InvestmentFrom Series A to B: Navigating the transition from promise to proof
From Series A to B: Navigating the transition from promise to proof
Investors at LSX Investival discuss how, after securing Series A funding, biotech companies should begin to lay the groundwork for Series B financing.
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
C-Suite Conversations
See all
Europe's Largest Springtime Biotech Partnering Event
REGISTERNews from APAC
See all
partneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
From Series A to B: Navigating the transition from promise to proof
Investors at LSX Investival discuss how, after securing Series A funding, biotech companies should begin to lay the groundwork for Series B financing.
Picky pharma prone to better proven partners amid dealmaking downturn
Pharma is being more selective in the deals it strikes among what a panel of experts say is an abundance of players looking to partner.
Successful mentorship between investors and CEOs hangs on respect
The unavoidable tension between effective mentorship between investors and CEOs is hard, but possible through mutual respect and understanding.